期刊文献+

妇产科病理学近十年的进展 被引量:4

Development of gynecological and obstetrical pathology in the past ten years
原文传递
导出
出处 《中华病理学杂志》 CAS CSCD 北大核心 2005年第10期619-622,共4页 Chinese Journal of Pathology
  • 相关文献

参考文献16

二级参考文献41

  • 1王建六,任品金,许心杰.正常卵巢及卵巢肿瘤雌、孕激素受体的研究[J].河南医科大学学报,1993,28(2):134-136. 被引量:1
  • 2韩守威,何斌,唐茜萍,刘珊玲,彭芝兰,曹泽毅.女性生殖系统恶性肿瘤组织胞浆雌激素及孕激素受体的研究[J].中华妇产科杂志,1994,29(1):12-15. 被引量:27
  • 3Wei H, Bowen R, Cai Q, et al. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med,1995, 208 : 124-130. 被引量:1
  • 4Katdare M, Osborne M, Telang NT. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol,2002, 21: 809-815. 被引量:1
  • 5Grothey A, Hashizume R, Ji H, et al. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene, 2000, 19:4864-4875. 被引量:1
  • 6O'Dwyer PJ, Stevenson JP, Gallagher M, et al. c-raf-1 depletion and tumor responses in patients treated with the c-raf-1 antisense oligodeoxynucleotide ISIS 5132 (CGP 69846A). Clin Cancer Res,1999, 5: 3977-3982. 被引量:1
  • 7Pan B, Yao KS, Monia BP, et al. Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582 ): evidence for the role of transcription factor overexpmssion in determining resistant phenotype. Biochem Pharmacol, 2002, 63: 1699-1707. 被引量:1
  • 8Grundker C, Volker P, Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial ando varian cancer cells through G protein alpha( l)-mediated activation of phosphotyrosine phosphatase. Endocrinology, 2001, 142: 2369-2380. 被引量:1
  • 9King BL, Carter D, Foellmer HG, et al. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.Am J Pathol, 1992, 140: 23-31. 被引量:1
  • 10Gullick WJ, Srinivasan R. The type 1 growth factor receptor family:new ligands and receptors and their role in breast cancer. Breast Cancer Res Treat, 1998, 52: 43-53. 被引量:1

共引文献144

同被引文献67

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部